Blog

EVENTS

FTFA Attendance at World Trade Organization Annual Trade and Public Health Workshop

On October 3rd, FTFA was invited by the World Trade Organization to speak at a closed-door panel discussion about “Substandard, Falsified and Counterfeit Medical Products” alongside the World Health Organization and the World Customs Organization. The event brought together country representatives from 30+ countries in the context of WTO’s annual Trade and Public Health Workshop. Photo: Andrea Vassalotti, Director of Partnerships and Programmes at the World Heart Federation and Chair of the Fight Read more…

By Fight the Fakes, 1 yearOctober 11, 2024 ago

RESOURCES

Minilab Updated Protocol to Detect Antifreeze in Children’s Cough Syrups

The Global Pharma Health Fund (GPHF), a non-profit organization supported by Merck KGaA, is pleased to announce the Special Edition 2024, featuring a new Minilab test for detecting the toxic antifreeze agents diethylene glycol (DEG) and ethylene glycol (EG). The GPHF-Minilab is a portable mini-laboratory designed to detect substandard, falsified, and adulterated medicines, especially in regions lacking advanced analytical tools. It offers a cost-effective solution to enhance testing capacity, often supplementing existing laboratories. DEG and EG, toxic industrial solvents, Read more…

By Fight the Fakes, 1 yearOctober 8, 2024 ago

PRESS RELEASES & STATEMENTS

Université la Source Conakry joins Fight the Fakes Alliance to strengthen coalition against substandard and falsified medical products

September 24, 2024, Location – Fight the Fakes Alliance is excited to announce and welcome the Université la Source Conakry as the newest member of the Alliance. Given that one-fifth of medicines in Africa are potentially substandard or falsified (SFs), and that SFs in sub-Saharan kill almost 500,000 people each year, this partnership is monumental in building and expanding the reach of Fight the Fakes campaign in a critical region. Université la Source Conakry’s commitment Read more…

By Fight the Fakes, 2 yearsSeptember 24, 2024 ago

UPDATES

Falsified (contaminated) Oxymorphone Hydrochloride 40mg identified in the WHO Region for Europe

Medical Product Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg Alert Summary This WHO Medical Product Alert refers to one batch of falsified Oxymorphone Hydrochloride 40mg. The falsified product was detected in the unregulated supply chain in Finland and reported to WHO in July 2024 by the Finnish Medicines Agency (FIMEA). Oxymorphone Hydrochloride is a semi-synthetic opioid used to treat moderate to severe pain. Laboratory analysis of samples of the falsified product, however, found that the Read more…

By Fight the Fakes, 2 yearsAugust 6, 2024 ago

UPDATES

BBC article on the devastating effects surrounding the online purchases of fake semaglutide

On July 31st, 24, BBC published an article on the devastating effects surrounding the online purchases of fake semaglutide – an active ingredient in legal drugs like Ozempic, a type 2 diabetes drug, and Wegovy, a weight loss drug. The article interviewed a member of Fight the Fakes Alliance, Oksana Pyzik, a professor at UCL School of Pharmacy. You can access the full BBC article here. Semaglutide, the active ingredient in slimming drugs, has been Read more…

By Fight the Fakes, 2 yearsAugust 1, 2024 ago

UPDATES

SF Pulse | July 2024

Our third SF Pulse Issue is out! SF Pulse is a bi-monthly newsletter that aims to elevate important issues and relevant stories shaping the ongoing fight against substandard and falsified medical products (SFs). The newest issue includes 7 important updates across many topics including: A blog post from a financial company’s senior employee where he emphasizes the necessity of cross-sector collaboration against substandard and falsified medicines and the harm SFs have against all industries. A Read more…

By Fight the Fakes, 2 yearsJuly 31, 2024 ago

PRESS RELEASES & STATEMENTS

Fight the Fakes Alliance launches report on Identifying Critical Enablers in the Prevention, Detection, and Response to Substandard and Falsified Medicines

This report highlights the urgent need for enhanced education, collaboration, and country-based initiatives to curb the growing global crisis. Geneva, Switzerland July 29th, 2024 – Fight the Fakes Alliance (FTFA) has released its white paper on Identifying Critical Enablers in the Prevention, Detection, and Response to Substandard and Falsified Medicines . The report assesses the current challenges in the global fight against SFs and offers actionable solutions to address what is one of the fastest-growing criminal Read more…

By Fight the Fakes, 2 yearsJuly 30, 2024 ago

RESOURCES

APEC Launches Supply Chain Security Toolkit for Medical Products

On Friday, 26th July, the FDA, FTFA member USP, and the Asia Pacific Economic Cooperation (APEC) announced the launch of the new web-based version of APEC’s Supply Chain Security (SCS) Toolkit, an essential resource designed to enhance the quality and security of medical products across the global supply chain. Securing the global medical product supply chain is a complex task that requires collaboration between regulatory bodies, industry stakeholders, non-governmental organizations, civil society, and international organizations. Read more…

By Fight the Fakes, 2 yearsJuly 30, 2024 ago

UPDATES

New York Times’ Article on the Rise of Counterfeit Ozempic and the Risk of Buying Drugs Online

On July 12, 2024, the New York Times published an article on the rise of counterfeit Ozempic and highlighting the greater risk of buying drugs online. The article interviewed a member of Fight the Fake Alliance, Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines. You can access the full NYTimes article here. As Ozempic and other weight loss drugs grow in popularity, there is a growing concern regarding the accessibility of fake Read more…

By Fight the Fakes, 2 yearsJuly 23, 2024 ago

UPDATES

The growing threat of SFs featured in an article by newspaper Swissinfo

On July 4, 2024, Swissinfo published an article on the growing problem of fake medicines on their front page. The article quotes a number of Fight the Fakes Alliance (FTFA) members including the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Alliance itself. The piece highlights that counterfeit drug sales have become one of the fastest-growing criminal enterprises in the world. It is estimated to be worth between USD$200 billion and USD$432 Read more…

By Fight the Fakes, 2 yearsJuly 11, 2024 ago

Subscribe to our Newsletter